(Total Views: 136)
Posted On: 12/14/2020 12:05:46 PM
Post# of 15407

$INCY News Article - Incyte Announces Results of Phase 3 RUXCOVID Study of Ruxolitinib (Jakafi ) as a Treatment for Patients with COVID-19 Associated Cytokine Storm https://marketwirenews.com/news-releases/incy...43366.html


My Twitter: WhyteStocks